WGS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 27.30%

Insider Buying (Last 12 Months): $4,121,270.44

Insider Selling (Last 12 Months): $103,449,641.94

GeneDx Insider Trading History Chart

GeneDx Share Price & Price History

^$69.38

▼ -1.66 (-2.34%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

GeneDx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Katherine Stueland	CEO	Sell	22,307	$70.34	$1,569,074.38	60,011
11/18/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	126,782	$70.78	$8,973,629.96	2,719,692
11/15/2024	Katherine Stueland	CEO	Sell	23,108	$70.48	$1,628,651.84	82,318
11/15/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	20,359	$69.78	$1,420,651.02	2,846,474
10/31/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	865,800	$75.00	$64,935,000.00	2,866,833
10/29/2024	Katherine Stueland	CEO	Sell	2,154	$66.60	$143,456.40	105,426
10/29/2024	Kevin Feeley	CFO	Sell	274	$66.60	$18,248.40	44,951
9/9/2024	Katherine Stueland	CEO	Sell	3,639	$33.33	$121,287.87	95,457
9/9/2024	Kevin Feeley	CFO	Sell	895	$33.33	$29,830.35	39,910
9/3/2024	Kevin Feeley	CFO	Sell	262	$31.71	$8,308.02	38,343
8/19/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$34.49	$1,724,500.00	2,646,972
8/15/2024	Opko Health, Inc.	Major Shareholder	Sell	39,824	$33.08	$1,317,377.92	2,746,972
8/12/2024	Opko Health, Inc.	Major Shareholder	Sell	59,787	$33.95	$2,029,768.65	2,811,783
8/8/2024	Opko Health, Inc.	Major Shareholder	Sell	100,000	$31.82	$3,182,000.00	2,871,570
8/6/2024	Opko Health, Inc.	Major Shareholder	Sell	12,994	$29.35	$381,373.90	2,971,570
7/31/2024	Opko Health, Inc.	Major Shareholder	Sell	88,839	$33.50	$2,976,106.50	2,984,564
7/29/2024	Katherine Stueland	CEO	Sell	2,154	$33.54	$72,245.16	92,550
7/29/2024	Kevin Feeley	CFO	Sell	274	$33.54	$9,189.96	37,888
7/29/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$33.86	$1,693,000.00	3,073,403
7/26/2024	Opko Health, Inc.	Major Shareholder	Sell	60,000	$33.85	$2,031,000.00	3,123,403
7/24/2024	Opko Health, Inc.	Major Shareholder	Sell	75,000	$33.72	$2,529,000.00	3,183,403
7/22/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$32.61	$1,630,500.00	3,333,403
7/19/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.29	$807,250.00	3,383,403
7/17/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.93	$823,250.00	3,408,403
7/5/2024	Opko Health, Inc.	Major Shareholder	Sell	36,118	$28.24	$1,019,972.32	3,433,403
7/3/2024	Opko Health, Inc.	Major Shareholder	Sell	14,082	$28.23	$397,534.86	3,469,521
7/1/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$26.63	$1,331,500.00	3,508,603
6/17/2024	Katherine Stueland	CEO	Sell	7,683	$28.31	$217,505.73	90,830
6/17/2024	Kevin Feeley	CFO	Sell	2,646	$28.31	$74,908.26	37,409
6/10/2024	Katherine Stueland	CEO	Sell	2,652	$24.92	$66,087.84	79,763
6/10/2024	Kevin Feeley	CFO	Sell	895	$24.92	$22,303.40	32,858
6/3/2024	Casdin Capital, Llc	Director	Buy	100,000	$20.82	$2,082,000.00	3,063,509
5/28/2024	Casdin Capital, Llc	Director	Buy	18,304	$20.61	$377,245.44	2,923,509
5/23/2024	Casdin Capital, Llc	Director	Buy	7,500	$19.59	$146,925.00	2,761,009
5/13/2024	Casdin Capital, Llc	Director	Buy	50,000	$23.31	$1,165,500.00	2,753,509
4/29/2024	Katherine Stueland	CEO	Sell	6,325	$11.04	$69,828.00	75,869
4/29/2024	Kevin Feeley	CFO	Sell	1,104	$11.04	$12,188.16	30,836
3/18/2024	Kareem Saad	Insider	Sell	2,008	$10.59	$21,264.72	29,517
3/18/2024	Katherine Stueland	CEO	Sell	8,559	$10.59	$90,639.81	66,698
3/18/2024	Kevin Feeley	CFO	Sell	3,253	$10.59	$34,449.27	28,927
3/4/2024	Casdin Capital, Llc	Director	Buy	40,000	$8.74	$349,600.00	2,702,609
1/22/2024	Kareem Saad	Insider	Sell	193	$3.24	$625.32	24,467
1/3/2024	Kareem Saad	Insider	Sell	105	$2.58	$270.90	24,114
12/18/2023	Kareem Saad	Insider	Sell	1,700	$2.16	$3,672.00	23,946
12/18/2023	Katherine Stueland	CEO	Sell	11,734	$2.16	$25,345.44	52,578
12/18/2023	Kevin Feeley	CFO	Sell	2,948	$2.16	$6,367.68	23,035
12/4/2023	Kevin Feeley	CFO	Sell	270	$1.77	$477.90	17,232
11/16/2023	Jason Ryan	Chairman	Buy	56,742	$1.27	$72,062.34	56,742
11/8/2023	Richard C Pfenniger Jr	Director	Buy	10,000	$1.49	$14,900.00	20,918
10/20/2023	Kareem Saad	Insider	Sell	164	$3.44	$564.16	18,541
10/17/2023	Jason Ryan	Chairman	Sell	42	$3.19	$133.98	5,834
10/3/2023	Kareem Saad	Insider	Sell	85	$3.56	$302.60	18,159
9/18/2023	Kareem Saad	Insider	Sell	1,580	$4.16	$6,572.80	17,971
9/18/2023	Katherine Stueland	CEO	Sell	10,752	$4.16	$44,728.32	42,689
9/18/2023	Kevin Feeley	CFO	Sell	2,742	$4.16	$11,406.72	16,785
9/11/2023	Kareem Saad	Insider	Sell	846	$4.62	$3,908.52	14,437
9/11/2023	Katherine Stueland	CEO	Sell	2,675	$4.62	$12,358.50	34,691
9/11/2023	Kevin Feeley	CFO	Sell	904	$4.62	$4,176.48	12,330
9/5/2023	Kevin Feeley	CFO	Sell	269	$4.38	$1,178.22	10,772
8/17/2023	Richard C Pfenniger Jr	Director	Buy	5,000	$5.10	$25,500.00	10,918
7/26/2023	Karen Ann White	Insider	Sell	61	$7.41	$452.01	4,761
7/20/2023	Kareem Saad	Insider	Sell	163	$7.85	$1,279.55	12,442
7/3/2023	Karen Ann White	Insider	Sell	45	$5.99	$269.55	4,685
6/20/2023	Karen Ann White	Insider	Sell	1,549	$6.37	$9,867.13	4,631
6/20/2023	Katherine Stueland	CEO	Sell	7,965	$6.37	$50,737.05	30,819
6/20/2023	Kevin Feeley	CFO	Sell	2,744	$6.37	$17,479.28	10,324
6/13/2023	Kevin Feeley	CFO	Sell	903	$6.49	$5,860.47	5,871
6/12/2023	Karen Ann White	Insider	Sell	828	$6.49	$5,373.72	2,770
6/12/2023	Katherine Stueland	CEO	Sell	2,674	$6.49	$17,354.26	20,034
6/2/2023	Kevin Feeley	CFO	Sell	263	$7.00	$1,841.00	4,312
5/18/2023	Richard C Pfenniger Jr	Director	Buy	5,000	$5.90	$29,500.00	5,918
5/16/2023	Katherine Stueland	CEO	Sell	8,685	$6.50	$56,452.50	16,162
5/16/2023	Kevin Feeley	CFO	Sell	1,516	$6.50	$9,854.00	3,856
4/26/2023	Karen Ann White	Insider	Sell	61	$9.57	$583.77	1,703
4/20/2023	Kareem Saad	Insider	Sell	161	$10.23	$1,647.03	5,979
4/3/2023	Karen Ann White	Insider	Sell	52	$11.22	$583.44	1,627
3/10/2023	Karen Ann White	Insider	Sell	993	$11.88	$11,796.84	1,580
3/10/2023	Katherine Stueland	CEO	Sell	2,807	$11.88	$33,347.16	9,350
3/10/2023	Kevin Feeley	CFO	Sell	965	$11.88	$11,464.20	2,359
1/4/2023	Karen Ann White	Insider	Sell	49	$8.58	$420.42	543
12/2/2022	Kevin Feeley	CFO	Sell	256	$13.20	$3,379.20	460
12/1/2022	Keith A Meister	Director	Sell	205,738	$13.20	$2,715,741.60	610,360
11/28/2022	Katherine Stueland	CEO	Buy	5,611	$17.82	$99,988.02	5,611
10/26/2022	Karen Ann White	Insider	Sell	60	$33.66	$2,019.60	493
10/20/2022	Kareem Saad	Insider	Sell	164	$29.37	$4,816.68	2,906
10/17/2022	Jason Ryan	Chairman	Sell	38	$28.38	$1,078.44	479
10/3/2022	Kareem Saad	Insider	Sell	80	$31.02	$2,481.60	2,525
8/25/2022	Richard Miao	CFO	Sell	105	$39.60	$4,158.00	753
8/9/2022	Isaac Ro	CFO	Sell	613	$65.67	$40,255.71	7,395
7/26/2022	Daniel Emmett Clark	General Counsel	Sell	38	$48.51	$1,843.38	9,460
7/26/2022	Karen Ann White	Insider	Sell	62	$48.51	$3,007.62	361
7/20/2022	Kareem Saad	Insider	Sell	160	$52.80	$8,448.00	2,333
5/20/2022	Eric Schadt	Insider	Buy	3,030	$63.36	$191,980.80	7,375
5/11/2022	Shawn Assad	CAO	Sell	94	$57.75	$5,428.50	972
5/10/2022	Isaac Ro	CFO	Sell	591	$81.18	$47,977.38	6,114
4/29/2022	Keith A Meister	Director	Buy	346,590	$132.00	$45,749,880.00	816,098
4/29/2022	Tactical Opportunit Blackstone	Major Shareholder	Buy	75,757	$132.00	$9,999,924.00	813,308
4/28/2022	Anthony Prentice	Insider	Sell	51	$71.94	$3,668.94	298
4/28/2022	Daniel Emmett Clark	General Counsel	Sell	36	$71.94	$2,589.84	9,380
4/20/2022	Kareem Saad	Insider	Sell	189	$82.17	$15,530.13	1,948
4/6/2022	Isaac Ro	CFO	Sell	38	$96.03	$3,649.14	4,812
2/11/2022	Shawn Assad	CAO	Sell	110	$120.12	$13,213.20
2/10/2022	Isaac Ro	CFO	Sell	658	$118.80	$78,170.40
1/28/2022	Anthony Prentice	Insider	Sell	61	$93.72	$5,716.92
1/28/2022	Daniel Emmett Clark	General Counsel	Sell	45	$93.72	$4,217.40
1/28/2022	Eric Schadt	CEO	Sell	881	$93.72	$82,567.32
11/29/2021	Isaac Ro	CFO	Sell	367	$218.79	$80,295.93

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for GeneDx (NASDAQ:WGS)

61.72% of GeneDx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GeneDx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	18,921	$0.80M	0.0%	+346.3%	0.069%
11/16/2024	Geode Capital Management LLC	377,631	$16.03M	0.0%	+8.7%	1.375%
11/15/2024	Barclays PLC	18,921	$0.80M	0.0%	+346.3%	0.069%
11/15/2024	State Street Corp	314,914	$13.37M	0.0%	+18.3%	1.146%
11/15/2024	Point72 DIFC Ltd	5,192	$0.22M	0.0%	N/A	0.019%
11/15/2024	Point72 Asset Management L.P.	293,671	$12.46M	0.0%	+87.4%	1.069%
11/15/2024	Jacobs Levy Equity Management Inc.	67,776	$2.88M	0.0%	-66.5%	0.247%
11/14/2024	Fred Alger Management LLC	394,230	$16.73M	0.1%	N/A	1.435%
11/14/2024	Verition Fund Management LLC	25,845	$1.10M	0.0%	+12.9%	0.094%
11/14/2024	Summit Partners Public Asset Management LLC	172,945	$7.34M	0.2%	N/A	0.630%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	7,647	$0.33M	0.0%	N/A	0.028%
11/14/2024	MetLife Investment Management LLC	7,297	$0.31M	0.0%	N/A	0.027%
11/14/2024	Healthcare of Ontario Pension Plan Trust Fund	177,500	$7.53M	0.0%	N/A	0.646%
11/13/2024	FMR LLC	53,825	$2.28M	0.0%	+295.6%	0.196%
11/12/2024	Alpha DNA Investment Management LLC	10,236	$0.43M	0.2%	-26.2%	0.037%
11/12/2024	Algert Global LLC	66,128	$2.81M	0.1%	+386.2%	0.241%
11/12/2024	Charles Schwab Investment Management Inc.	147,034	$6.24M	0.0%	+304.3%	0.535%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	60,005	$2.55M	0.0%	N/A	0.218%
11/8/2024	Thompson Davis & CO. Inc.	14,600	$0.62M	0.5%	-33.2%	0.053%
11/6/2024	Royce & Associates LP	28,293	$1.20M	0.0%	N/A	0.105%
11/5/2024	GSA Capital Partners LLP	7,577	$0.32M	0.0%	N/A	0.028%
11/4/2024	Lisanti Capital Growth LLC	36,615	$1.55M	0.4%	N/A	0.136%
11/4/2024	Chartwell Investment Partners LLC	40,573	$1.72M	0.1%	N/A	0.151%
10/31/2024	Principal Financial Group Inc.	14,240	$0.60M	0.0%	N/A	0.053%
10/28/2024	Palumbo Wealth Management LLC	6,761	$0.29M	0.1%	N/A	0.026%
10/23/2024	Assenagon Asset Management S.A.	329,256	$13.97M	0.0%	-10.1%	1.260%
10/21/2024	Precision Wealth Strategies LLC	8,574	$0.36M	0.3%	N/A	0.033%
10/18/2024	Raymond James & Associates	190,619	$8.09M	0.0%	N/A	0.730%
10/8/2024	CWM LLC	2,091	$89K	0.0%	N/A	0.008%
10/3/2024	SG Americas Securities LLC	4,667	$0.20M	0.0%	N/A	0.018%
8/19/2024	Point72 Asset Management L.P.	156,745	$4.10M	0.0%	+227.4%	0.600%
8/16/2024	Algert Global LLC	13,602	$0.36M	0.0%	N/A	0.052%
8/16/2024	Driehaus Capital Management LLC	433,635	$11.34M	0.1%	N/A	1.660%
8/15/2024	The Manufacturers Life Insurance Company	11,102	$0.29M	0.0%	N/A	0.043%
8/15/2024	Millennium Management LLC	311,401	$8.14M	0.0%	+193.5%	1.192%
8/15/2024	Alpha DNA Investment Management LLC	13,875	$0.36M	0.1%	N/A	0.053%
8/14/2024	Squarepoint Ops LLC	59,949	$1.57M	0.0%	+124.9%	0.229%
8/14/2024	Cubist Systematic Strategies LLC	76,701	$2.01M	0.0%	+573.5%	0.294%
8/14/2024	Oracle Investment Management Inc.	1,105,768	$28.91M	27.0%	-1.8%	4.233%
8/13/2024	Divisadero Street Capital Management LP	225,170	$5.89M	0.9%	N/A	0.862%
8/9/2024	Renaissance Technologies LLC	90,373	$2.36M	0.0%	N/A	0.346%
8/8/2024	American Century Companies Inc.	17,258	$0.45M	0.0%	+36.1%	0.066%
8/6/2024	Acadian Asset Management LLC	1,323	$34K	0.0%	N/A	0.005%
8/1/2024	Rhumbline Advisers	18,360	$0.48M	0.0%	+8,096.4%	0.070%
7/31/2024	nVerses Capital LLC	1,900	$50K	0.0%	N/A	0.007%
7/26/2024	Bank of New York Mellon Corp	37,918	$0.99M	0.0%	N/A	0.145%
7/25/2024	Calamos Advisors LLC	43,488	$1.14M	0.0%	N/A	0.166%
7/23/2024	Thompson Davis & CO. Inc.	21,844	$0.57M	0.5%	-9.3%	0.084%
7/18/2024	Assenagon Asset Management S.A.	366,296	$9.58M	0.0%	N/A	1.402%
7/11/2024	Legal Advantage Investments Inc.	19,800	$0.52M	0.3%	N/A	0.076%
5/16/2024	Jacobs Levy Equity Management Inc.	202,063	$1.85M	0.0%	-35.6%	0.774%
5/15/2024	Oracle Investment Management Inc.	1,126,607	$10.29M	6.8%	+531.7%	4.313%
5/14/2024	Gagnon Securities LLC	556,305	$5.08M	1.2%	+59.3%	2.130%
5/14/2024	Gagnon Advisors LLC	211,393	$1.93M	1.7%	+41.6%	0.809%
5/10/2024	Vanguard Group Inc.	707,612	$6.46M	0.0%	+4.2%	2.709%
5/2/2024	Thompson Davis & CO. Inc.	24,094	$0.22M	0.1%	+20.8%	0.092%
4/22/2024	PFG Investments LLC	10,424	$95K	0.0%	N/A	0.040%
2/14/2024	Oracle Investment Management Inc.	178,354	$0.49M	0.3%	-82.1%	0.689%
2/12/2024	Decheng Capital LLC	103,604	$0.29M	0.1%	N/A	0.400%
2/5/2024	Thompson Davis & CO. Inc.	19,944	$55K	0.0%	+99.4%	0.077%
11/14/2023	Oracle Investment Management Inc.	994,580	$3.62M	1.1%	+14.9%	3.843%
11/14/2023	Blackstone Inc.	835,062	$3.04M	0.0%	-8.8%	3.227%
11/8/2023	HighTower Advisors LLC	237,948	$0.87M	0.0%	+14.1%	0.923%
11/8/2023	Pathstone Family Office LLC	54,327	$0.20M	0.0%	+262.2%	0.211%
10/24/2023	Trellus Management Company LLC	155,012	$0.56M	0.8%	+55.0%	0.602%
8/14/2023	Oracle Investment Management Inc.	865,849	$5.16M	3.8%	-96.6%	3.384%
8/14/2023	Casdin Capital LLC	3,095,511	$18.45M	1.6%	-97.0%	12.097%
8/14/2023	Prelude Capital Management LLC	19,391	$0.12M	0.0%	N/A	0.076%
8/8/2023	Gagnon Advisors LLC	149,319	$0.89M	0.6%	N/A	0.584%
8/8/2023	Gagnon Securities LLC	363,567	$2.17M	0.5%	N/A	1.421%
7/28/2023	Decheng Capital Management III Cayman LLC	103,604	$0.62M	0.2%	-97.0%	0.405%
7/27/2023	Victory Capital Management Inc.	11,617	$69K	0.0%	N/A	0.045%
7/14/2023	Trellus Management Company LLC	100,036	$0.60M	0.7%	N/A	0.391%
5/16/2023	Altium Capital Management LP	4,588,000	$1.68M	0.9%	N/A	18.969%
5/10/2023	Decheng Capital Management III Cayman LLC	3,418,929	$1.25M	0.5%	N/A	14.134%
5/10/2023	Thompson Davis & CO. Inc.	140,000	$51K	0.1%	N/A	0.579%
5/2/2023	Evolution Wealth Advisors LLC	86,824	$32K	0.0%	N/A	0.023%
5/2/2023	Victory Capital Management Inc.	342,519	$0.13M	0.0%	+1,743.9%	0.091%
4/20/2023	Trellus Management Company LLC	1,500,000	$0.55M	0.6%	+36.4%	0.398%
4/10/2023	Gagnon Advisors LLC	4,299,896	$1.57M	1.1%	+481.8%	1.140%
4/10/2023	Gagnon Securities LLC	9,934,183	$3.63M	0.8%	+829.1%	2.633%
2/13/2023	The Manufacturers Life Insurance Company	137,480	$33K	0.0%	-33.2%	0.036%
2/7/2023	Gagnon Securities LLC	1,069,264	$0.28M	0.1%	-2.2%	0.283%
2/7/2023	Zweig DiMenna Associates LLC	1,420,383	$0.38M	0.1%	+6.0%	0.377%
1/27/2023	Trellus Management Company LLC	1,100,000	$0.29M	0.4%	+148.4%	0.292%
11/15/2022	Marshall Wace LLP	5,650,286	$4.97M	0.0%	+14.9%	1.498%
11/14/2022	Oracle Investment Management Inc.	8,403,926	$7.37M	4.2%	+27.6%	2.228%
11/14/2022	Gagnon Securities LLC	1,093,068	$0.96M	0.2%	-42.4%	0.290%
11/14/2022	Gagnon Advisors LLC	739,100	$0.65M	0.4%	-50.0%	0.196%
11/14/2022	Difesa Capital Management LP	100,000	$88K	0.0%	-23.1%	0.027%
10/31/2022	SG Americas Securities LLC	99,986	$88K	0.0%	+50.7%	0.027%
10/28/2022	Zweig DiMenna Associates LLC	1,339,883	$1.18M	0.3%	+4.3%	0.355%
10/25/2022	Trellus Management Company LLC	442,900	$0.39M	0.5%	-27.4%	0.117%
8/16/2022	Casdin Capital LLC	16,437,500	$20.71M	1.8%	+228.8%	4.357%
8/16/2022	Corvex Management LP	15,937,500	$20.08M	1.3%	+254.2%	4.225%
8/16/2022	Deerfield Management Company L.P. Series C	18,848,488	$23.75M	0.5%	+36.1%	4.996%
8/11/2022	Deutsche Bank AG	2,266,585	$2.86M	0.0%	+3.4%	0.601%
8/9/2022	Swiss National Bank	230,700	$0.29M	0.0%	-10.1%	0.061%
8/3/2022	Tuttle Capital Management LLC	24,595	$31K	0.1%	N/A	0.007%
8/1/2022	Gagnon Securities LLC	1,898,752	$2.39M	0.5%	+0.3%	0.503%

Data available starting January 2016

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $69.38

$68.04

$71.46

50 Day Range

MA: $58.11

$36.84

$84.02

52 Week Range

Now: $69.38

$1.29

$89.11

Volume

458,804 shs

Average Volume

451,000 shs

Market Capitalization

$1.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of GeneDx?: GeneDx's top insider shareholders include:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Keith A Meister (Director)
Katherine Stueland (CEO)
Jason Ryan (Chairman)
Kevin Feeley (CFO)
Kareem Saad (Insider)
Richard C Pfenniger Jr (Director)
Karen Ann White (Insider)
Learn More about top insider investors at GeneDx.
Who are the major institutional investors of GeneDx?: GeneDx's top institutional shareholders include:
Fred Alger Management LLC — 1.44%
Geode Capital Management LLC — 1.37%
Assenagon Asset Management S.A. — 1.26%
State Street Corp — 1.15%
Point72 Asset Management L.P. — 1.07%
Raymond James & Associates — 0.73%
Learn More about top institutional investors of GeneDx stock.
Which major investors are selling GeneDx stock?: During the last quarter, WGS stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Assenagon Asset Management S.A.
Thompson Davis & CO. Inc.
Alpha DNA Investment Management LLC
In the last year, company insiders that have sold GeneDx company stock include:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Keith A Meister (Director)
Katherine Stueland (CEO)
Learn More investors selling GeneDx stock.
Which major investors are buying GeneDx stock?: In the last quarter, WGS stock was bought by institutional investors including:
Fred Alger Management LLC
Raymond James & Associates
Healthcare of Ontario Pension Plan Trust Fund
Summit Partners Public Asset Management LLC
Point72 Asset Management L.P.
Charles Schwab Investment Management Inc.
Connor Clark & Lunn Investment Management Ltd.
Algert Global LLC
During the previous year, these company insiders have bought GeneDx stock:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Keith A Meister (Director)
Learn More investors buying GeneDx stock.

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

WGS Insider Trading

GeneDx Insider Trading History Chart

GeneDx Share Price & Price History

GeneDx Insider Trading History

SEC Filings (Institutional Ownership Changes) for GeneDx (NASDAQ:WGS)

Institutional Buying and Selling by Quarter

GeneDx Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of GeneDx?

Who are the major institutional investors of GeneDx?

Which major investors are selling GeneDx stock?

Which major investors are buying GeneDx stock?